Enabling individualized therapy through nanotechnology.
(49/1062)
(+info )Behavioural therapy in the treatment of obesity (I): new directions for clinical practice.
(50/1062)
(+info )Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.
(51/1062)
(+info )Individualizing dosing of irinotecan.
(52/1062)
(+info )A CYP3A4 phenotype-based dosing algorithm for individualized treatment of irinotecan.
(53/1062)
(+info )Protein microarrays for personalized medicine.
(54/1062)
(+info )Rapid genotyping of single nucleotide polymorphisms influencing warfarin drug response by surface-enhanced laser desorption and ionization time-of-flight (SELDI-TOF) mass spectrometry.
(55/1062)
(+info )Combining targeted therapies: practical issues to consider at the bench and bedside.
(56/1062)
(+info )